Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Rakuten Medical, MD Anderson Pair Up on Cancer Photoimmunotherapy
June 8, 2020
- Eylea Pre-Filled Syringe Now Available in Japan: Bayer, Santen
June 8, 2020
- Nipro Launches Stemirac Manufacturing Facility in Tokyo
June 8, 2020
- Latuda to Finally Hit Japan Market on June 11
June 5, 2020
- Opdivo Top-Selling Drug in May, Keytruda Falls to Second: Encise
June 5, 2020
- Kyowa Kirin Looks to Make Crysvita 1st In-House Blockbuster, Sees 100 Billion Yen Target “Not Unachievable”
June 5, 2020
- Humira Remains Global Top-Seller in 2019
June 4, 2020
- Lilly Expects Topline Data for 2 COVID-19 Drug Candidates by June-End, First Patient Dosed in Antibody Treatment Study: Japan Execs
June 3, 2020
- Shionogi Aims at 500 Billion Yen Sales in FY2024: New 5-Year Plan
June 3, 2020
- Kyowa Hakko Bio’s GMP Breach Triggers Shipment Curbs, Stockouts at Astellas, Kowa; Impact Could Reverberate Further
June 3, 2020
- Asahi Kasei Pharma Grabs China Approval for Flivas
June 3, 2020
- Eisai’s Insomnia Med Dayvigo Now Available in US
June 3, 2020
- Fetroja Gets FDA’s Priority Review for Nosocomial Pneumonia
June 3, 2020
- Relugolix Combo Filed in US for Uterine Fibroids
June 3, 2020
- Torii, ASKA to Copromote Riona for Iron Deficiency Anemia
June 2, 2020
- 15 Drug Makers See 3.6% Negative Growth in Japan in FY2020 as Re-Pricing, Generic Entries Weigh: Jiho Tally
June 2, 2020
- Onivyde Now Available in Japan: Servier/Yakult
June 2, 2020
- Daiichi Sankyo to Test TROP2-Directed ADC plus Keytruda in NSCLC
June 2, 2020
- Takeda Launching Project to Gauge Parkinson’s Symptoms with Wearables, Telemedicine Platform
June 2, 2020
- Takeda Gets CHMP Backing for Takhzyro Pre-Filled Syringe
June 2, 2020
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…